Biotricity, Inc. (BTCY)
NASDAQ: BTCY · IEX Real-Time Price · USD
1.480
+0.210 (16.54%)
At close: Apr 18, 2024, 4:00 PM
1.420
-0.060 (-4.05%)
After-hours: Apr 18, 2024, 7:08 PM EDT

Biotricity Balance Sheet

Millions USD. Fiscal year is Apr - Mar.
Year 2022202120202019201820172016201620152014
Cash & Equivalents
0.6612.152.20.950.060.840.420.020.410.45
Cash & Cash Equivalents
0.6612.152.20.950.060.840.420.020.410.45
Cash Growth
-94.61%451.97%131.78%1392.37%-92.46%98.57%1956.58%-94.97%-8.47%-
Receivables
1.322.011.570.530.2100000
Inventory
2.340.840.270.090.0200000
Other Current Assets
0.410.320.280.090.160.050.020.010.080.07
Total Current Assets
4.7215.324.321.660.460.90.440.030.490.52
Property, Plant & Equipment
1.611.270.070.26000000
Other Long-Term Assets
0.180.090.050.080.030.030.030.030.030
Total Long-Term Assets
1.791.360.120.350.030.030.030.030.030
Total Assets
6.5116.684.4420.490.930.470.070.520.52
Accounts Payable
5.042.62.521.521.40.761.141.320.410.18
Current Debt
5.111.754.342.280.8701.561.310.780
Other Current Liabilities
1.010.523.630002.161.510.560
Total Current Liabilities
11.164.8710.493.82.270.764.864.141.760.18
Long-Term Debt
14.4413.60.370.06000000
Other Long-Term Liabilities
0.760.350.411.14000000
Total Long-Term Liabilities
15.213.960.781.2000000
Total Liabilities
26.3618.8211.2752.270.764.864.141.760.18
Total Debt
19.5515.354.712.340.8701.561.310.780
Debt Growth
27.31%226.18%101.30%169.49%--18.97%66.97%--
Retained Earnings
-112.57-93.04-62.82-46.36-35.04-26.45-18.31-16.51-9.23-4.04
Comprehensive Income
-0.15-0.77-0.63-0.86-0.75-0.64-0.41-0.26-0.020.02
Shareholders' Equity
-19.85-2.14-6.83-3-1.780.17-4.38-4.07-1.240.34
Net Cash / Debt
-18.89-3.2-2.51-1.39-0.80.84-1.13-1.29-0.370.45
Net Cash Per Share
-2.18-0.42-0.40-0.23-0.140.17-0.26-0.30-0.100.19
Working Capital
-6.4410.46-6.17-2.14-1.810.14-4.42-4.1-1.270.34
Book Value Per Share
-2.29-0.28-1.09-0.50-0.320.03-1.02-0.95-0.340.14
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).